Giovanbattista D'Amico

Retinal and circulating miRNA expression patterns in diabetic retinopathy: An in silico and in vivo approach

F. Drago, S. Rossi, C. Bucolo, 2019, British journal of pharmacology.

Galectin 1—A Key Player between Tissue Repair and Fibrosis

A. Hermenean, Alina Ciceu, M. Trotta, 2022, International journal of molecular sciences.

Systemic Beta-Hydroxybutyrate Affects BDNF and Autophagy into the Retina of Diabetic Mice

G. Pieretti, S. Rossi, F. Simonelli, 2022, International journal of molecular sciences.

The activation of retinal HCA2 receptors by systemic beta-hydroxybutyrate inhibits diabetic retinal damage through reduction of endoplasmic reticulum stress and the NLRP3 inflammasome

C. Bucolo, A. Hermenean, F. Guida, 2019, PloS one.

Serum Iba-1, GLUT5, and TSPO in Patients With Diabetic Retinopathy: New Biomarkers for Early Retinal Neurovascular Alterations? A Pilot Study

S. Rossi, F. Simonelli, A. Hermenean, 2022, Translational vision science & technology.

Inhibition of Galectins and the P2X7 Purinergic Receptor as a Therapeutic Approach in the Neurovascular Inflammation of Diabetic Retinopathy

S. Rossi, F. Simonelli, A. Hermenean, 2023, International journal of molecular sciences.

The Melanocortin System in Inflammatory Bowel Diseases: Insights into Its Mechanisms and Therapeutic Potentials

A. Federico, A. Gravina, M. Dallio, 2023, Cells.